Atypical antipsychotic use is an independent predictor for the increased mean platelet volume in patients with schizophrenia: A preliminary study
Background: Cardiovascular diseases, cardiovascular risk factors, and mortality due to these situations are more frequently encountered in schizophrenic patients when compared with the general population. The mean platelet volume (MPV) is a surrogate biomarker of the platelet activity and an useful...
Main Authors: | Murat Semiz, Hasan Yücel, Önder Kavakçı, Osman Yıldırım, Ali Zorlu, Mehmet Birhan Yılmaz, Zekeriya Küçükdurmaz, Fatih Canan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2013;volume=18;issue=7;spage=561;epage=566;aulast=Semiz |
Similar Items
-
THE ROLE OF ATYPICAL ANTIPSYCHOTIC DECREASING AGGRESIVENESS IN SCHIZOPHRENIA
by: Juvita Novia Anggraini Maria
Published: (2013-03-01) -
Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-08-01) -
EFFECT OF TYPICAL AND ATYPICAL ANTIPSYCHOTICS ON PLASMA PROLACTIN LEVELS IN SCHIZOPHRENIA
by: Muhammad Sami Bilal, et al.
Published: (2015-01-01) -
Pharmacoeconomic comparison of ziprasidone with other atypical oral antipsychotic agents in schizophrenia
by: Andrea Fagiolini, et al.
Published: (2011-11-01) -
Metformin for the Prevention of Weight Gain due to Atypical Antipsychotics
by: Nazmiye Kaya, et al.
Published: (2011-06-01)